FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
News|Articles|February 18, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 18, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, February 18, 2022, at 3:37 PM, EDT:
43.1% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
According to the CDC as of today, February 18, 2022, at 3:37 PM, EDT:
• 64.6% of total US population
• 68.7% of US population aged ≥5 years
• 73.2% of US population aged ≥12 years
• 74.7% of US population aged ≥18 years
• 88.6% of US population aged ≥65 years
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Puerto Rico: 80.8%
2. Rhode Island: 80.3%
3. Vermont: 80%
4. Maine: 78.2%
5. Connecticut: 77.5%
2. Rhode Island: 80.3%
3. Vermont: 80%
4. Maine: 78.2%
5. Connecticut: 77.5%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, February 18, 2022 at 3:21 PM, EDT, there have been:
• 78 333 189 confirmed cases and
• 933 154 deaths
• 933 154 deaths
The 5 states with the highest total confirmed cases are:
1. California: 8 883 873
2. Texas: 6 556 314
3. Florida: 5 776 333
4. New York: 4 899 936
5. Illinois: 3 013 709
2. Texas: 6 556 314
3. Florida: 5 776 333
4. New York: 4 899 936
5. Illinois: 3 013 709
Deaths: California has the highest number of deaths due to COVID-19 with 83 762 reported fatalities, followed by Texas with 83 225 and Florida with 68 572.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 420 944 864 confirmed cases, 5 869 585 deaths, and 10 316 706 676 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
ACOG's new guideline covers hormone therapy timing, neurokinin receptor antagonists, SSRIs/SNRIs, and nonpharmacologic options for menopause symptoms.
Post hoc LUCENT-2 and VIVID-1 analyses show more mirikizumab-treated patients reached steroid-free composite remission in UC and Crohn disease at 1 year.
The FDA granted Breakthrough Device designation to Natera's cell-free DNA multi-cancer early detection assay. What it means for primary care.
Most adolescents with sporadic colorectal cancer present with stage III or IV disease, and few have a family history, per data presented at AAP 2026.
Advertisement
Advertisement
Trending on Patient Care Online
1
Who Should Get a CGM? Expanding the Primary Care Candidate Pool
2
FDA Grants Breakthrough Device Designation to Natera's Multi-Cancer Early Detection Blood Test
3
Mirikizumab Linked to Higher Rates of Corticosteroid-Free Composite Remission in UC and Crohn Disease
4
ACOG Issues Expanded Guideline on Managing Menopause-Related Vasomotor, Sleep, and Mood Symptoms
5